Compare LPAA & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LPAA | FDMT |
|---|---|---|
| Founded | 2024 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.3M | 455.4M |
| IPO Year | 2024 | 2020 |
| Metric | LPAA | FDMT |
|---|---|---|
| Price | $10.60 | $7.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $30.33 |
| AVG Volume (30 Days) | 68.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | ★ $120,000.00 |
| Revenue This Year | N/A | $21,181.08 |
| Revenue Next Year | N/A | $162.43 |
| P/E Ratio | $31.79 | ★ N/A |
| Revenue Growth | N/A | ★ 605.88 |
| 52 Week Low | $10.04 | $2.24 |
| 52 Week High | $10.70 | $12.34 |
| Indicator | LPAA | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 63.04 | 30.51 |
| Support Level | $10.57 | $7.67 |
| Resistance Level | $10.60 | $11.81 |
| Average True Range (ATR) | 0.02 | 0.74 |
| MACD | -0.00 | -0.24 |
| Stochastic Oscillator | 50.00 | 4.06 |
Launch One Acquisition Corp is a blank check company.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.